Table 1.
Characteristic | Penicillamine Group (N = 40) | NABTT Reference Group (N = 179) | P |
---|---|---|---|
Sex (male) | 25 (63%) | 119 (66%) | 0.63 |
Race (white) | 38 (95%) | 171 (96%) | 0.88 |
Age (years) | 53.8 (9.4) | 56.2 (10.9) | 0.19 |
Karnofsky performance status | 88.0 (8.8) | 86.7 (11.2)† | 0.49 |
Extent of surgery (biopsy) | 7 (18%) | 32 (18.1%)† | 1.0 |
Baseline demographics values are expressed either as the mean (SD) or N (%) from the NABTT database of 179 patients for studies evaluating biological therapies in newly diagnosed glioblastoma with microscopic or macroscopic disease.
N = 178 for Karnofsky performance status, and n = 177 for extent of surgery because of incomplete data.